Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
6.85    0.70 (11.11%)
Bid:
6.70
Ask:
7.00
Spread: 0.30 (4.478%)
Market Cap: £10.49m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Block Listing Update - Warrant Plan

30 Jan 2026 16:50

RNS Number : 1709R
Ondo InsurTech PLC
30 January 2026
 

30 January 2026

Ondo InsurTech plc

("Ondo" or the "Company")

 

 

Block listing Application Update

 

 

Ondo InsurTech Plc (LSE: ONDO) announces that under the Block Listing application announced on 5 July 2023 application was made for a block listing of 33,037,918 ordinary shares of 5p each ("Ordinary Shares") to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange. The purpose of the block listing was to facilitate the future issue and admission to trading of shares pursuant to the exercise of share warrants under the various warrant instruments issued by the Company.

 

The Company has subsequently received application to exercise, or the warrants have otherwise lapsed, in respect of 30,626,255 Ordinary Shares.

 

As a result, the Company has now one warrant programme remaining in respect of the 5,191,669 Fund Raising Warrants issued in May 2023. Of these warrants, 2,411,663 remain to be exercised on or before 22 May 2026.

 

Name of applicant:

Ondo InsurTech Plc

Name of scheme:

Fund Raise Warrants

 

Period of return:

From:

1 August 2025

To:

30 Jan 2026

 

Balance of unallotted securities under scheme(s) from previous return:

4,330,003

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,918,340

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,411,663

 

 

Enquiries

 

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

 

+44 (0) 800 783 9866

 

Dowgate Capital Ltd

(Joint Broker & Financial Advisor)

 

Russell Cook

Daniel Ingram

Amber Philipps

 

+44 (0) 20 3903 7715

Singer Capital Markets

(Joint Broker)

 

Charles Leigh-Pemberton

Asha Chotai

James Todd

 

+44 (0) 20 7496 3000

www.singercm.com

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

+44 (0) 7949 690338

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSRLTIIVIR
Date   Source Headline
26th Aug 20257:00 amRNS-RTopdanmark agreement update
15th Aug 20253:00 pmRNSNotice of AGM
4th Aug 20254:47 pmRNSHolding(s) in Company
4th Aug 20253:10 pmRNSHolding(s) in Company
4th Aug 20257:00 amRNSDirectorate Change
1st Aug 20251:32 pmRNSDirector/PDMR Shareholding
1st Aug 20259:03 amRNSBlock listing Interim Review
1st Aug 20258:56 amRNSTotal Voting Rights
30th Jul 20257:30 amRNSWarrant Exercise
30th Jul 20257:00 amRNSAnnual Financial Report
28th Jul 20251:44 pmRNSHolding(s) in Company
24th Jul 20257:00 amRNS-RLeakBot Partnership with vipHomeLink in the U.S.
7th Jul 20251:00 pmRNSNotice of Results
1st Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 20257:30 amRNSTotal Voting Rights
30th Jun 20257:05 amRNSDirector/PDMR Shareholding
26th Jun 202512:30 pmRNSDirector/PDMR Shareholding
19th Jun 20254:01 pmRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSBear River Mutual to Pilot LeakBot in the US
12th Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 202510:01 amRNSDirector/PDMR Shareholding
6th May 202512:34 pmRNSHolding(s) in Company
1st May 202510:00 amRNSDirector/PDMR Shareholding
1st May 202510:00 amRNSTotal Voting Rights
15th Apr 20255:06 pmRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSThe Hanover to pilot LeakBot in the United States
11th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
2nd Apr 20257:00 amRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSTotal Voting Rights
11th Mar 20254:56 pmRNSDirector/PDMR Share Dealing
4th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNS-RMutual of Enumclaw to Expand LeakBot Program
3rd Mar 20257:00 amRNSTotal Voting Rights
17th Feb 20257:00 amRNS-RPURE expands LeakBot program
13th Feb 20257:00 amRNSTrading Update
13th Feb 20257:00 amRNSLiberty Mutual Insurance to Pilot LeakBot in US
5th Feb 202511:54 amRNSWarrant Exercise and Director/PDMR Shareholding
3rd Feb 20252:02 pmRNSDirector/PDMR Shareholding and TVR - Replacement
3rd Feb 20257:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
3rd Feb 20257:00 amRNSBlock listing Interim Review
31st Jan 20257:00 amRNS-RNorthumbrian Water to trial LeakBot
20th Jan 20253:40 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20245:58 pmRNSBlock Listing Application - Amendment
20th Dec 20243:12 pmRNSBlock Listing Application
20th Dec 20247:00 amRNSDirector/PDMR Shareholding
5th Dec 20241:22 pmRNSExercise of Options
5th Dec 202412:21 pmRNSTotal Voting Rights
4th Dec 20247:00 amRNSShare Incentive Plan Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.